ArticleTherapeutic advances in gastroenterology2026
Impact of timing of access to endoscopic drainage and social determinants of health on the prognosis of patients with periampullary cancer diagnosed through jaundice: a multicenter retrospective study.
Article in Therapeutic advances in gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Factors influencing the timing to endoscopic retrograde cholangiopancreatography (ERCP) drainage in patients with periampullary cancer diagnosed due to jaundice, as well as the impact of drainage delay on survival, remain poorly understood. Objectives: To evaluate the impact of clinical and social determinants on time to ERCP and 1-year mortality in patients with periampullary cancer diagnosed due to jaundice. Design: Multicenter retrospective study. Methods: All ERCP performed for periampullary cancer diagnosed due to jaundice between January 2010 and December 2020 were included. Determinants associated with early ERCP (defined as ⩽3 days from diagnostic imaging) were assessed using logistic regression. Factors associated with 1-year mortality were analyzed using a multivariate Cox model. Results: Five hundred ninety-four ERCPs were performed, with a median time to intervention of 9 days. Early ERCP (⩽3 days) was associated with improved survival in univariate analysis (hazard ratio (HR) = 0.66; 95% confidence interval (CI) (0.45-0.96)), but not in the multivariate model. In multivariate analysis, acute cholangitis (HR = 1.51; 95% CI (1.03-2.22)), age (HR = 1.03; 95% CI (1.01-1.04)), metastatic disease (HR = 1.76; 95% CI (1.21-2.57)), and ERCP technical success (HR = 0.59; 95% CI (0.42-0.83)) were associated with 1-year mortality. Only total bilirubin (odds ratio (OR) = 2.24; 95% CI (1.18-4.23)) and prothrombin time (OR = 1.02; 95% CI (1.01-1.04)) influenced time to ERCP. Social determinants had no significant impact on time to ERCP or overall survival. Conclusion: Time to ERCP does not appear to influence overall survival in patients with periampullary cancer diagnosed due to jaundice. Overall survival and time to ERCP seem to be influenced by clinical factors, with no apparent effect of social determinants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.